BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30607517)

  • 21. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
    Häuser W; Petzke F; Sommer C
    J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibromyalgia: poorly understood; treatments are disappointing.
    Prescrire Int; 2009 Aug; 18(102):169-73. PubMed ID: 19746561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia.
    Choy E; Marshall D; Gabriel ZL; Mitchell SA; Gylee E; Dakin HA
    Semin Arthritis Rheum; 2011 Dec; 41(3):335-45.e6. PubMed ID: 21868065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects and management of fibromyalgia syndrome.
    Chong YY; Ng BY
    Ann Acad Med Singap; 2009 Nov; 38(11):967-73. PubMed ID: 19956819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].
    Sommer C; Alten R; Bär KJ; Bernateck M; Brückle W; Friedel E; Henningsen P; Petzke F; Tölle T; Üçeyler N; Winkelmann A; Häuser W
    Schmerz; 2017 Jun; 31(3):274-284. PubMed ID: 28493231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibromyalgia and sleep.
    Spaeth M; Rizzi M; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):227-39. PubMed ID: 22094198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygen therapy vs. pharmacological intervention in adults with fibromyalgia related to childhood sexual abuse: prospective, randomized clinical trial.
    Boussi-Gross R; Catalogna M; Lang E; Shamai Z; Ablin JN; Aloush V; Doenyas-Barak K; Lorberboym M; Lev-Wiesel R; Efrati S
    Sci Rep; 2024 May; 14(1):11599. PubMed ID: 38773296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study.
    Ichesco E; Peltier SJ; Mawla I; Harper DE; Pauer L; Harte SE; Clauw DJ; Harris RE
    Arthritis Rheumatol; 2021 Nov; 73(11):2127-2137. PubMed ID: 33982890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D; Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of pharmacological therapies in fibromyalgia syndrome.
    Häuser W; Walitt B; Fitzcharles MA; Sommer C
    Arthritis Res Ther; 2014 Jan; 16(1):201. PubMed ID: 24433463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk for Medication Nonadherence Among Medicaid Enrollees With Fibromyalgia: Development of a Validated Risk Prediction Tool.
    Desai R; Jo A; Marlow NM
    Pain Pract; 2019 Mar; 19(3):295-302. PubMed ID: 30369018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment data from the Brazilian fibromyalgia registry (EpiFibro).
    de Assis MR; Dos Santos Paiva E; Helfenstein M; Heymann RE; Pollak DF; Provenza JR; Ranzolin A; Rezende MC; Ribeiro LS; Souza EJR; Martinez JE
    Adv Rheumatol; 2020 Jan; 60(1):9. PubMed ID: 31964420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes.
    Arnold LM; Clauw DJ
    Am J Med; 2010 Jun; 123(6):S2. PubMed ID: 20569735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newer treatments for fibromyalgia syndrome.
    Harris RE; Clauw DJ
    Ther Clin Risk Manag; 2008 Dec; 4(6):1331-42. PubMed ID: 19337439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.
    Häuser W; Arnold B; Eich W; Felde E; Flügge C; Henningsen P; Herrmann M; Köllner V; Kühn E; Nutzinger D; Offenbächer M; Schiltenwolf M; Sommer C; Thieme K; Kopp I
    Ger Med Sci; 2008 Dec; 6():Doc14. PubMed ID: 19675740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective.
    Lloyd A; Boomershine CS; Choy EH; Chandran A; Zlateva G
    J Med Econ; 2012; 15(3):481-92. PubMed ID: 22339078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine Uses in Patients With Kidney Disease: Different Recommendations From the United States Versus Europe and Canada.
    Nguyen T; Shoukhardin I; Gouse A
    Am J Ther; 2019; 26(4):e516-e519. PubMed ID: 29419534
    [No Abstract]   [Full Text] [Related]  

  • 38. A systematic review of pharmacoeconomic studies for pregabalin.
    Parker L; Huelin R; Khankhel Z; Wasiak R; Mould J
    Pain Pract; 2015 Jan; 15(1):82-94. PubMed ID: 24815038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.